1. Home
  2. EQIX vs SNY Comparison

EQIX vs SNY Comparison

Compare EQIX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equinix Inc. REIT

EQIX

Equinix Inc. REIT

N/A

Current Price

$1,023.71

Market Cap

103.1B

Sector

Real Estate

ML Signal

N/A

Logo Sanofi ADS

SNY

Sanofi ADS

N/A

Current Price

$40.15

Market Cap

95.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EQIX
SNY
Founded
1998
1994
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.1B
95.7B
IPO Year
2000
2001

Fundamental Metrics

Financial Performance
Metric
EQIX
SNY
Price
$1,023.71
$40.15
Analyst Decision
Buy
Buy
Analyst Count
34
10
Target Price
★ $1,234.19
$53.61
AVG Volume (30 Days)
427.1K
★ 2.6M
Earning Date
10-28-2026
10-30-2026
Dividend Yield
2.04%
★ 4.39%
EPS Growth
★ 61.88
N/A
EPS
★ 9.04
N/A
Revenue
★ $5,998,545,000.00
N/A
Revenue This Year
$11.09
$2.25
Revenue Next Year
$10.87
$6.26
P/E Ratio
$111.85
★ $6.14
Revenue Growth
★ 7.85
N/A
52 Week Low
$720.62
$39.18
52 Week High
$1,128.68
$52.68

Technical Indicators

Market Signals
Indicator
EQIX
SNY
Relative Strength Index (RSI) 48.22 34.81
Support Level $995.64 N/A
Resistance Level $1,058.34 $45.22
Average True Range (ATR) 21.96 0.57
MACD 1.01 -0.05
Stochastic Oscillator 40.80 27.18

Price Performance

Historical Comparison
EQIX
SNY

About EQIX Equinix Inc. REIT

Equinix is one of the leading providers of cloud- and carrier-neutral data centers, offering colocation and interconnection services to hyperscalers and businesses. Equinix operates 270 properties in 77 metropolitan areas across 36 countries, serving over 10,000 customers. About 70% of Equinix's revenue comes from renting physical space, which allows hyperscalers and other clients to store servers, data storage, and networking equipment. The other 30% of revenue is generated primarily through interconnection services (20%) and other managed services (10%).

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: